SCHEMBL23336043

SCHEMBL23336043

c1ccc(-c2nc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)nc(-c3cc(-c4ccccc4)c(-c4cc5ccccc5c5ccccc45)cc3-c3ccccc3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.41
▸ ATM Q13315 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ CYP11B1 P15538 1/20 0.37
▸ HDAC4 P56524 1/20 0.34
▸ KMT2A Q03164 5/20 0.33
▸ MEN1 O00255 4/20 0.33
▸ MAPT P10636 4/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ HPGD P15428 3/20 0.33
▸ RXRA P19793 1/20 0.33
▸ MPI P34949 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ GPR84 Q9NQS5 2/20 0.33
▸ PTPN1 P18031 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ ESR1 P03372 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ IL1R1 P14778 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21191468 0.92 ATM (0.46) KDM4EATML3MBTL1CYP11B1HDAC4
SCHEMBL23336203 0.92 KDM4E (0.46) KDM4EATML3MBTL1CYP11B1HDAC4
SCHEMBL23336040 0.91 KDM4E (0.41) KDM4EATML3MBTL1CYP11B1HDAC4
SCHEMBL17943393 0.91 ATM (0.45) KDM4EATML3MBTL1CYP11B1HDAC4
SCHEMBL23336202 0.90 KDM4E (0.40) KDM4EATML3MBTL1CYP11B1HDAC4
SCHEMBL22664000 0.89 L3MBTL1 (0.52) KDM4EATML3MBTL1HDAC4KMT2A
SCHEMBL23154441 0.89 L3MBTL1 (0.52) KDM4EATML3MBTL1HDAC4KMT2A
SCHEMBL23336208 0.89 CYP11B1 (0.39) KDM4EATML3MBTL1CYP11B1HDAC4
SCHEMBL17943447 0.88 KDM4E (0.43) KDM4EATML3MBTL1CYP11B1HDAC4
SCHEMBL23336041 0.87 CYP11B1 (0.37) KDM4EATML3MBTL1CYP11B1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220407011-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE SOULBRAIN CO., LTD. (KR) 2022-12-22 — — US disclosed
WO-2021086142-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING SAME, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE 솔브레인 주식회사 2021-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220407011-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE OCIAD1, AOX1, OXER1 KDM4E 2841/4885ATM 3966/4885L3MBTL1 116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback